NCT05719844 Interest of an Attentional Evaluation by a Computerized Battery in the Management of Concussion in Young Rugby Players
| NCT ID | NCT05719844 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Clermont-Ferrand |
| Condition | Concussion, Brain |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2023-03-09 |
| Primary Completion | 2027-03-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2023-03-09 with a primary completion date of 2027-03-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to test the ability of a computerized neuropsychological battery to identify attentional disorders resulting from a concussion occurring during the practice of rugby. Thirty young people with a concussion (11-25 years old) will take several neuropsychological tests. Researchers will compare their results with those of young athletes without concussion to see the effect of concussion.
Eligibility Criteria
Inclusion Criteria: * Patients : * concussion in the context of the practice of rugby * French or reading French without help * Controls : * no concussion * practicing a non-contact sport (athletics, rowing, badminton, capoeira, circus, running, crossfit, cycling, dancing, climbing, fencing, fitness, golf, gymnastics, bodybuilding, swimming, skating, Qi Gong, Taï chi, tennis, table tennis, shooting, trail running, volleyball, water polo) within a sports association * age matched to patient (+/- 1 year) * study level matched to patient (+/- 1 year) * French or reading French without help Exclusion Criteria: * Patients : * Legal protection measure * Other neurological or psychiatric pathologies prior to concussion episodes * Diagnosis of a neurodevelopmental disorder in childhood * Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation) * Addictive behaviors * Current major depressive disorder or treated with antidepressants or benzodiazepines for less than 3 months * Severe visual or motor problems that may interfere with the performance of the tests * Controls : * Legal protection measure * History of proven concussion * Other neurological or psychiatric pathologies * Diagnosis of a neurodevelopmental disorder in childhood * Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation) * Addictive behaviors * Current major depressive episode or treated with antidepressants or benzodiazepines for less than 3 months * Severe visual or motor problems that may interfere with the performance of the tests
Contact & Investigator
Tiphaine Vidal
PRINCIPAL INVESTIGATOR
University Hospital, Clermont-Ferrand
Frequently Asked Questions
Who can join the NCT05719844 clinical trial?
This trial is open to male participants only, aged 11 Years or older, up to 25 Years, studying Concussion, Brain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05719844 currently recruiting?
Yes, NCT05719844 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.
Where is the NCT05719844 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France.
Who is sponsoring the NCT05719844 clinical trial?
NCT05719844 is sponsored by University Hospital, Clermont-Ferrand. The principal investigator is Tiphaine Vidal at University Hospital, Clermont-Ferrand. The trial plans to enroll 90 participants.